Asarfi Hospital Ltd

ASARFIHospital
181.55+0.00 (+0.00%)
As on 30 Jan 2026, 01:41 pmMarket Closed

Fundamental Score

...

Asarfi Hospital Ltd Share Price Live NSE/BSE

No data
High
0.00
Low
0.00
Volume
0
Change
+0.00%

Profitability Metrics

Poor

Return on Equity

14.06%
Average

Return on Capital Employed

15.83%
Excellent

Operating Profit Margin (5Y)

18.82%
Poor

Dividend Yield

0.00%

Valuation Metrics

Excellent

Price to Earnings

27.39x

Market Capitalization

384.79 (Cr)

Industry P/E

52.84x

Growth Metrics

Excellent

YoY Quarterly Profit Growth

48.28%
Excellent

YoY Quarterly Sales Growth

45.33%
Excellent

Sales Growth (5Y)

22.13%
Poor

EPS Growth (5Y)

-24.05%
Excellent

Profit Growth (5Y)

32.35%

Financial Health

Poor

Debt to Equity

0.54x
Excellent

Interest Coverage

4.99x
Poor

Free Cash Flow (5Y)

-55.41 (Cr)

Ownership Structure

Good

Promoter Holding

61.17%
Poor

FII Holding

0.05%
Poor

DII Holding

2.18%
Excellent

Pledged Percentage

0.00%
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.
61.17%
Promoter Holding
384.79 (Cr)
Market Cap

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Market Data Analysis & Educational Insights

Educational evaluation of ASARFI across key market metrics for learning purposes.

Positive Indicators

9 factors identified

Excellent ROCE Performance (15.83%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance. This indicates quality business fundamentals.

Strong Operating Margins (18.82%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages. This indicates sustainable profitability potential.

Attractive Valuation (P/E: 27.39 vs Industry: 52.84)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity if fundamentals support the business case.

Robust Profit Growth (48.28%)

Observation: Strong year-over-year profit expansion demonstrates business momentum.

Analysis: Profit growth >20% indicates effective execution and market opportunity capture. This suggests positive business trajectory.

Strong Revenue Growth (45.33%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential. This indicates business expansion success.

Consistent Growth Track Record (22.13% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model and market opportunity execution over time.

Strong Profit Growth Track Record (32.35% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model and effective operational leverage over time.

Balanced Promoter Holding (61.17%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment while ensuring adequate liquidity.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral, reducing forced-selling risk.

Analysis: Absence of share pledging eliminates potential forced-selling pressure during market stress.

Risk Factors

5 factors identified

Weak Earnings Growth (-24.05% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation. Consider growth catalysts and competitive positioning.

Negative Free Cash Flow (₹-55.41 Cr over 5Y)

Observation: Cash outflows exceed inflows, indicating capital intensity or working capital issues.

Analysis: Negative FCF requires analysis of capital expenditure cycle and working capital management efficiency.

Limited Institutional Interest (FII+DII: 2.23%)

Observation: Low institutional participation may affect liquidity and visibility.

Analysis: Limited institutional interest may indicate size constraints or visibility issues in the investment community.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints. Assess capital allocation strategy.

Small Market Cap

Observation: Higher investment risk due to limited size.

Analysis: Small-cap stocks typically carry higher volatility and liquidity risks.

Financial Statements

Comprehensive financial data for Asarfi Hospital Ltd

About ASARFI

Business Overview

Asarfi Hospital Limited operates a hospital under the Asarfi Hospital name in India. The company offers primary health services, such as health camp and health education center, drug distribution, vaccination, health, and hygiene awareness program, as well as operates yoga and exercise center, health resort, and health information center. Asarfi Hospital Limited was incorporated in 2005 and is based in Dhanbad, India.

Company Details

Symbol:ASARFI
Industry:Hospital
Sector:Hospital

Key Leadership

Mr. Udai Pratap Singh
MD & Director
Mr. Harendra Singh
CFO & Director
Ms. Madhuri Singh
Executive Director

ASARFI Stock Details & Analysis

Key Financial Metrics

Return on Equity (ROE)14.06%
Return on Capital Employed15.83%
Operating Profit Margin (5Y)18.82%
Debt to Equity Ratio0.54
Interest Coverage Ratio4.99

Growth & Valuation

Sales Growth (5Y)22.13%
Profit Growth (5Y)32.35%
EPS Growth (5Y)-24.05%
YoY Quarterly Profit Growth48.28%
YoY Quarterly Sales Growth45.33%

Frequently Asked Questions

What is the current price of Asarfi Hospital Ltd (ASARFI)?

As of 30 Jan 2026, 01:41 pm IST, Asarfi Hospital Ltd (ASARFI) is currently trading at ₹181.55. The stock has a market capitalization of ₹384.79 (Cr).

Is ASARFI share price Overvalued or Undervalued?

ASARFI is currently trading at a P/E ratio of 27.39x, compared to the industry average of 52.84x. Based on this relative valuation, the stock appears to be Undervalued against its sector peers.

What factors affect the Asarfi Hospital Ltd share price?

Key factors influencing ASARFI's price include its quarterly earnings growth (Sales Growth: 45.33%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Asarfi Hospital Ltd a good stock for long-term investment?

Asarfi Hospital Ltd shows a 5-year Profit Growth of 32.35% and an ROE of 14.06%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.54 before investing.

How does Asarfi Hospital Ltd compare with its industry peers?

Asarfi Hospital Ltd competes with major peers in the Hospital. Investors should compare ASARFI's P/E of 27.39x and ROE of 14.06% against the industry averages to determine its competitive standing.

What is the P/E ratio of ASARFI and what does it mean?

ASARFI has a P/E ratio of 27.39x compared to the industry average of 52.84x. The Price-to-Earnings (P/E) ratio is calculated by dividing the current share price by earnings per share (EPS). This means investors are paying ₹27 for every ₹1 of annual earnings.

How is ASARFI performing according to Bull Run's analysis?

ASARFI has a Bull Run fundamental score of 66.3/100, which indicates moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters including profitability, growth metrics, and valuation ratios.

What sector and industry does ASARFI belong to?

ASARFI operates in the Hospital industry. This classification helps understand the competitive landscape and sector-specific trends affecting Asarfi Hospital Ltd.

What is Return on Equity (ROE) and why is it important for ASARFI?

ASARFI has an ROE of 14.06%, which shows decent profitability but room for improvement. Return on Equity measures how efficiently Asarfi Hospital Ltd generates profits from shareholders' equity.

How is ASARFI's debt-to-equity ratio and what does it indicate?

ASARFI has a debt-to-equity ratio of 0.54, which indicates moderate leverage that should be monitored. A ratio below 1.0 generally indicates conservative financing.

What is ASARFI's dividend yield and is it a good dividend stock?

ASARFI offers a dividend yield of 0.00%, which means you receive ₹0.00 annual dividend for every ₹100 invested.

How has ASARFI grown over the past 5 years?

ASARFI has achieved 5-year growth rates of: Sales Growth 22.13%, Profit Growth 32.35%, and EPS Growth -24.05%.

What is the promoter holding in ASARFI and why does it matter?

Promoters hold 61.17% of ASARFI shares, with 0.00% of promoter shares pledged. High promoter holding often indicates strong management confidence.

What is ASARFI's market capitalization category?

ASARFI has a market capitalization of ₹385 crores, placing it in the Small-cap category.

How volatile is ASARFI stock?

ASARFI has a beta of N/A. A beta > 1 suggests the stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is the 52-week high and low for ASARFI?

ASARFI has a 52-week high of ₹N/A and low of ₹N/A.

What is ASARFI's operating profit margin trend?

ASARFI has a 5-year average Operating Profit Margin (OPM) of 18.82%, indicating the company's operational efficiency.

How is ASARFI's quarterly performance?

Recent quarterly performance shows YoY Sales Growth of 45.33% and YoY Profit Growth of 48.28%.

What is the institutional holding pattern in ASARFI?

ASARFI has FII holding of 0.05% and DII holding of 2.18%. Significant institutional holding often suggests professional confidence in the stock.